I came home the other day to a
local paper, the News and Observer, sitting on my desk. “Major Hospitals Pile Up The Cash” blazed
across the front page, encircled by pen with a bold exclamation point written
to the side. The article highlighted the
inflated costs of major North Carolina hospital networks – more than 10 percent
above the national average.
Large providers leverage their local
market share to increase prices without adding any new value in caring for
patients. These aggressive strategies
are done while maintaining tax-exemption from their non-profit status. The higher costs are passed to insurance
companies that, after tacking on a profit margin, pass the costs to their
patients, the community members for whom the hospitals supposedly exist to
serve.
U.S. healthcare spending is at a
concerning level. It is common for
patients and providers alike to point to the insurance industry as the villain,
insinuating that the implicit self-interest of a for-profit company must be
driving costs skyward. Though third-party
payers are a part of the problem, their role is likely that of an enabler
rather than a driver.
The complexity of insurance in
the U.S. shields consumers and physicians from the horrific levels of spending occurring
in the system. However, payers are
probably one of the few major stakeholders that are attempting to restrain
healthcare spending. Every charge from a
physician or hospital threatens to eat into their profits. It is a strange twist to see that in some
contexts, our beloved hospitals are driving costs up and our much despised
insurers may be fighting to keep costs down.
The Organization for Economic
Cooperation and Development (OECD) is a collection of the world’s most
industrialized nations; many of the members have comparable economic health to
the U.S. and the group provides an appropriate cohort to compare benchmarks for
the performance of given industries, such as healthcare.
You may ask yourself “compared to
OECD countries, do we really spend that much on healthcare?” Unfortunately, yes
we do. In 2000, the OECD median spending
on healthcare per capita was $1,983, the U.S. spent $4,631 – 137% greater than
the median and 44% more than the next highest country, Swizterland. Not only are we spending more in absolute
terms, but relatively as well; a greater part of our economy is dedicated to
healthcare, 13% of GDP in 2000 compared to the OECD median of 8.0%.1 These trends have only worsened over time.
In 2000, analysts noted a pattern
of convergence. Countries that were
spending more than average on healthcare had lower growth rates in healthcare
spending, and those spending less than average had higher spending growth
rates. A global, per-capita price to
healthcare was emerging. The U.S. was
the only country that defied this pattern; though it had the highest per-capita
cost, its growth rate was still above the OECD median.
The trends from that time have
changed very little. The U.S. remains
the most costly system in the world and we have yet to significantly shift the
growth curve of spending. This wouldn’t
be a major problem if we received appropriate value for the money spent. It seems, however, that is not the case. The U.S. averaged 118 hospital
admissions per 1000 patients, the average length of stay was 5.9 days, and the
acute care hospital days per capita was 0.7;
all of these user indicators were less than the OECD medians: 154
admissions, 6.4 days, and 1.0 acute care days respectively. We are paying more for less care.
Though inefficiency and higher
costs of inputs, such as supplies and labor, play a part, providers are finding
ways to increase prices without changing the services they provide. This brings us full circle to the sensational
news headline on my desk; large hospital networks can dominate a geographic
region, effectively monopolizing care. Healthcare
is unique in that it must be provided locally – care can never be outsourced
abroad or even to another state. Large nation-wide
insurance companies must accept higher rates from locally dominant networks.
It sounds a bit theoretical and
cerebral, but the concepts do play out in the real world; the price of a given
procedure is significantly associated with the size of the health network
offering the procedure. The News and
Observer, in their recent expose, reported that a local hospital charges 3 to 10
times the cost of many common procedures, basically because they can.
The current uncertainty about
healthcare reform is driving hospitals to strategically grow, acquiring
surrounding physician practices. As they
increase in size, so do they in market leverage. Physician groups join large networks to partake
in the bargaining power – their reimbursements increase with renegotiated
contracts but nothing of value is added.
The increased costs are then passed to patients, through insurance
companies.
As reform continues, we can
expect a heavy focus on the insurance industry; it is already the case with the
Supreme Court decision underway. Many providers
will likely support this focus, claiming that reforming insurance is essential
to cost control while simultaneously asserting that the stance is in the best
interest of the communities they serve.
We, as consumers of healthcare, should
be aware that a conflict of interest exists.
Providers historically have charged as much as they can get away
with. It is visible both in local
examples and comparative international trends, we should not expect otherwise
in the future. If our political dialogue
ignores the role of providers in the
pricing of care, a significant driver to our rising national spending will be
preserved.
That is all for now. Hopefully I have left your emotional state somewhere
between hope, fear, and a belief of the infinite. Until next time…
References
1. Anderson GF, Reinhardt UE, Hussey PS,
Petrosyan V. It’s the prices, stupid: Why the united states is so different
from other countries. Health Aff 2003;22(3):89-105.